Abandoned mines are often extremely contaminated by heavy metals and acid, creating a unique nutrient environment. Nonetheless, it has been recognized that microorganisms have adapted to life in this unique bioregion. 1 In the harsh conditions of an abandoned mine, microorganisms are likely to be subjected to substantial levels of competition, which could lead them to develop unique chemical arsenals, such as antibiotics. 2, 3 In the course of our study on the production of secondary metabolites by the mine actinomycete, Streptomyces sp. KMA-001 was isolated from a heat-treated soil sample (55 1C, 5 min) collected at the Yeonhwa abandoned zinc mine in Korea. From a pure culture of this strain, we have isolated a new aldgamycin derivative, aldgamycin I (1), along with four earlier reported 16-membered macrolides, aldgamycin E (2), 4,5 aldgamycin F (3), 6 aldgamycin G (4) 7 and chalcomycin (5) 8 (Figure 1) .
rDNA was performed using two universal primers 27f (5¢-AGA GTT TGA TCM TGG CTC AG-3¢) and 1492R (5¢-TAC GGH TAC CTT GTT ACG ACT T-3¢). 9 The PCR mixture consisted of 30 picomoles of each primer, 100 ng of chromosomal DNA, 200 mM dNTPs and 2.5 U of Taq polymerase in 50 ml of total volume. The amplification was carried out for 35 cycles at 94 1C for 30 s, annealing at 54 1C for 30 s and extension at 72 1C for 1.5 min. The PCR product was analyzed by agarose gel eletrophoresis and the remaining mixture was purified using a PCR purification kit (Solgent Co., Ltd, Daejeon, Korea). The 16S rDNA PCR product was sequenced by Solgent Co., Ltd. BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) was used to access the DNA similarities. The 16S rDNA sequence of KMA-001 strain showed a homology of 99.3% with Streptomyces goshikiensis NBRC 12868, S. citricolor NBRC 13005 and S. sporoverrucosus NBRC 15458. The cultured strain, KMA-001, was deposited with the Korean Culture Center of Microorganisms (KCCM42921).
The secondary metabolites of this bacterium were analyzed by HPLC-MS using a gradient solvent system, 10-100% CH 3 CN/water, for 30 min (flow rate 0.7 ml min À1 , column agilent eclipse XDB-C18, 4.6Â150 mm, 5 mm) daily for 7 days to observe temporal production. Five chromatographic peaks were selected for purification after comparison analysis with our in-house HPLC-MS-UV database. After 7 days of fermentation, 20 g l À1 Amberlite XAD-7 adsorbent resin (Supelco, Bellefonte, PA, USA) was added into each 1-l culture flask (the volume of broth 500 mlÂ25), and the mixture was shaken for an additional hour. The resin was then collected by filtration through cheesecloth, washed with deionized water and eluted twice with Me 2 CO. The crude extract was fractionated by C18 flash column chromatography using mixtures of MeOH-water (20, 40, 60, 80 and 100% MeOH in water, each 200 ml, flow rate 20 ml min À1 ) as elution solvents. The 60% MeOH fraction contained all the HPLC peaks of interest and was repurified by prep-HPLC with a Luna C18 (2) column (21.2Â250 mm, 15 mm, Phenomenex Inc., Torrance, CA, USA) using an acetonitrile-water (1.6:1 v/v) isocratic condition (flow rate 10 ml min À1 ) to yield five 16-membered macrolides, aldgamycin I (1, 16.0 mg), aldgamycin E (2, 5.4 mg), aldgamycin F (3, 4.0 mg), aldgamycin G (4, 3.5 mg) and chalcomycin (5, 12.0 mg). (Table 2) , which were confirmed by the presence of an ester carbonyl carbon at d C 165.6 and oxygenated carbons at d C 58.7 and 59.1 in the 13 C NMR spectrum. Comparison of 13 C NMR spectra of 1 and 3 was essentially identical except for C-3¢, C-4¢, C-7¢ and C-8¢ (1: d 74.8, 37.1, 70.0, and 16.7, aldgamycin F: d 85.0, 40.7, 81.5 and 13.0). Comprehensive NMR analysis, using data from HSQC, HMBC, 1 H-1 H COSY and 1 H-1 H TOCSY experiments allowed us to assign the structure of 1, which contained a decarboxylated D-aldgaroside, 4,6-dideoxy-3-C-(1-hydroxyethyl)-b-D-ribo-hexopyranose, instead of the D-aldgarose in earlier reported aldgamycin F (3). Aldgamycin I (1) was so named because aldgamycin H, an 8-dehydroxy derivative of 1, was described in an earlier French patent. 10 The absolute configuration of 1 was determined mainly by comparison of the CD spectral data of aldgamycin I (1) and aldgamycin F (3). Treatment of 1 and 3 (each 0.5 mg) in dry pyridine (1 ml) with dimethylaminopyridine (0.5 mg) and 4-bromo benzoyl chloride (2 mg) at room temperature for 12 h, in separate experiments, yielded the reaction mixture including, 7¢,4 00 -di-O-p-bromobenzoyl-aldgamycin I (6; Figure 1 ). Compound 6 was purified by normal phase HPLC (Gilson 321 system; Luna 10 m silica (2) 250Â10 mm column, Phenomenex Inc.; 4 ml min À1 ) using isocratic elution with hexane-EtOAc (2:1). Both products showed identical 1 H NMR and CD spectra (Figure 2) , as well as similar quasi-molecular ion peaks and retention times in LC-MS data. These data suggested that the absolute configuration of 1 was the same as that of 3.
Compound 2 was also obtained as a white amorphous powder that analyzed for the molecular formula C 37 H 58 O 15 by HR-FAB-MS ((M+H) + ¼743.3860) in combination with 1 H and 13 C NMR data. The IR absorption bands at 1800 and 1709 cm À1 suggested the presence of a ketone and an a,b-unsaturated carbonyl group. Analyses of the 2D NMR spectra of 2 allowed us to assign the structure of 2 as aldgamycin E, which was reported earlier. 5 The 1 H NMR spectrum of 2 is very similar to that of aldgamycin E, although the reported structure of aldgamycin E was defined incompletely and its sugar linkage position was not determined. Two sugar units and an aglycone of 2, as well as the optical rotation (2 À50.41 (CHCl 3 ); aldgamycin E À561 (CH 3 OH)) are the same as those of aldgamycin E. We, thus, proposed that the structure of 2 was identical to aldgamycin E. In addition to the 1 H NMR spectrum described earlier, the NMR data and the structure of compound 2 (Tables 1 and 2 ) need to be further described.
The absolute configurations of two sugar units of aldgamycin E were already described in an earlier literature. 5, 6 However, the aglycone of aldgamycin E was reported as a planar structure. In an earlier literature, the absolute configuration of GERI-155, a relative of chalcomycin, was assigned to be identical to that of chalcomycin on the similarities of their optical rotation values (GERI-155 [a] D À75.51; chalcomycin [a] D À43.51) and NMR data. 11 Similarly, compound 2 has a very similar optical rotation value as that of 4 (2, À50.41; 4, À29.01). This comparison is further strengthened when biosynthetic origins are considered. As these compounds were isolated from the same microbial culture, it is likely that compound 2 is produced through the same biosynthetic pathway as aldgamycin G, and is then reduced by an enoylreductase. 12 On the basis of the spectroscopic data and biosynthetic considerations, the absolute configuration of 2 is proposed to be identical to that of aldgamycin G (4). The antimicrobial activities of aldgamycin I (1), aldgamycin E (2), aldgamycin F (3), aldgamycin G (4) and chalcomycin (5) were measured using a MIC assay against Micrococcus luteus, Bacillus subtilis, Proteus vulgaris, Salmonella typhimurium, Aspergillus fumigatus, Trichophyton rubrum and methicillin resistant Staphylococcus aureus (Table 3) . Ampicillin and amphotericin B were used as positive controls in each assay. Interestingly, all compounds showed selective antibacterial activities against M. luteus and S. typhimurium. These compounds exhibited weak or no antimicrobial activities against B. subtilis, P. vulgaris, A. fumigatus, T. rubrum and MRSA as shown in Table 3 . 
